Safety and Efficacy Study of NovoRapid™ in Patients With Coexisting Diabetes and Kidney Disease

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

February 28, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Chronic Kidney Disease
Interventions
DRUG

insulin aspart

Safety and effectiveness data collection in connection with the use of the drug NovoRapid™ in patients with coexisting diabetes and chronic kidney disease in daily clinical practice.

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY